Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+ 3 oxidation state) methyltransferase (AS3MT) gene

Toxicology and Applied Pharmacology

Volumn 234, Issue 1, 2009, Pages 41-46

  Fujihara, Junko ^a   Fujii, Yoshimi ^a   Agusa, Tetsuro ^a   Kunito, Takashi ^b   Yasuda, Toshihiro ^c   Moritani, Tamami ^a   Takeshita, Haruo ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Arsenic; AS3MT; Ethnic differences; Genotyping method; Intron; PCR RFLP; Single nucleotide polymorphism (SNP)

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; METHYLTRANSFERASE;

ARSENIC POISONING; ARTICLE; BIOTRANSFORMATION; CARCINOGENICITY; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; JAPANESE; KOREAN; METHYLATION; MONGOLIAN; NEUROTOXICITY; NUCLEOTIDE SEQUENCE; OVAMBO; POLYMERASE CHAIN REACTION; REDUCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TURKISH;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ARSENIC; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HAPLOTYPES; HUMANS; INTRONS; JAPAN; KOREA; METHYLTRANSFERASES; MONGOLIA; NAMIBIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY; WATER POLLUTANTS, CHEMICAL;

EID: 57149107969     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.09.026     Document Type: Article

References (29)

1. Chowdhury U.K., Zakharyan R.A., Hernandez A., Avram M.D., Kopplin M.J., and Aposhian H.V. Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicol. Appl. Pharmacol. 216 (2006) 446-457
2. Crecelius E.A. Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19 (1977) 147-150
3. Drobna Z., Waters S.B., Walton F.S., LeCluyse E.L., Thomas D.J., and Styblo M. Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol. Appl. Pharmacol. 201 (2004) 166-177
4. Fujihara J., Kunito T., Agusa T., Yasuda T., Iida R., Fujii Y., and Takeshita H. Population differences in the human arsenic methyltransferase (AS3MT) gene polymorphism detected by using genotyping method. Toxicol. Appl. Pharmacol. 225 (2007) 251-254
5. Fujihara J., Shiwaku K., Yasuda T., Yuasa I., Nishimukai H., Iida R., and Takeshita H. Variation of interleukin 8 -251 A > T polymorphism in worldwide populations and intra-ethnic differences in Japanese populations. Clin. Chim. Acta 377 (2007) 79-82
6. Fujihara J., Shiwaku K., Xue Y., Kataoka K., Hieda Y., and Takeshita H. CYP1A2 polymorphism (C > A at position-163) in Ovambos, Koreans and Mongolians. Cell Biochem. Funct. 25 (2007) 491-494
7. Fujihara J., kunito T., and Takeshita H. Frequency of two human glutathione-S-transferase omega 1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method. Clin. Chem. Lab. Med. 45 (2007) 621-624
8. Fujihara J., Soejima M., Koda Y., Kunito T., and Takeshita H. Asian specific low mutation frequencies of the M287T polymorphism in the human arsenic (+ 3 oxidation state) methyltransferase (AS3MT) gene. Mutat. Res. 654 (2008) 158-161
9. 287Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. Mutat. Res. 637 (2008) 80-92
10. 287Thr allele carriers. Pharmacogenet. Genomics 18 (2008) 349-355
11. IARC. Some metals and metallic compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 23 (1980) 39-141
12. Kumar R., and Dunn L.L. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. Oncog. Res. 4 (1989) 235
13. Lin S., Shi Q., Nix F.B., Styblo M., Beck M.A., Herbin-Davis K.M., Hall L.L., Simeonsson J.B., and Thomas D.J. A novel S-adenosyl-L-methionine: arsenic (III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277 (2002) 10795-10803
14. Lindberg A.L., Kumar R., Goessler W., Thirumaran R., Gurzau E., Koppova K., Rudnai P., Leonardi G., Fletcher T., and Vahter M. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ. Health Perspect. 115 (2007) 1081-1086
15. V) Reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem. Res. Toxicol. 16 (2003) 1507-1513
16. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., and Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14 (2001) 355-361
17. Meza M., Yu L., Rodriguez Y.Y., Guild M., Thompson D., Gandolfi A.J., and Klimecki W.T. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphism in children. Environ. Health Perspect. 113 (2005) 775-781
18. Meza M.M., Gandolfi A.J., and Klimecki W.T. Developmental and genetic modulation of arsenic biotransformation: A gene by environmental interaction. Toxicol. Appl. Pharmacol. 222 (2007) 381-387
19. NRC. Arsenic in drinking water (1999), National Academy Press, Washington, DC
20. Petric J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., and Aposhian H.V. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163 (2000) 203-207
21. Rossman T.G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533 (2003) 37-65
22. Schläwicke Engström K.S., Broberg K., Concha G., Nermell B., Warholm M., and Vahter M. Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ. Health Perspect. 115 (2007) 599-605
23. Simeonova P.P., and Luster M.I. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?. J. Environ. Pathol. Toxicol. Oncol. 19 (2000) 281-286
24. Smith T.J., Crecelius E.A., and Reading J.C. Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ. Health Perspect. 19 (1977) 89-93
25. Stephens M., and Donelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 273 (2003) 1162-1169
26. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., and Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (2000) 289-299
27. Takeshita H., Fujihara J., Soejima M., Koda Y., Yasuda T., and Nakajima T. Extremely high prevalence of DNASE1*1 allele in African populations. Cell Biochem. Funct. 26 (2008) 151-153
28. Vahter M. Genetic polymorphism in the biotransformation of inorganic and its role in toxicity. Toxicol. Lett. 112-113 (2000) 209-217
29. Wood T.C., Salavagionne O.E., Mukherjee B., Wang L., Klumpp A.F., Thomae B.A., Eckloff B.W., Schaid D.J., Wieben E.D., and Weinshilboum R.M. Human arsenic methyltransferase (AS3MT) pharmacogenetics. J. Biol. Chem. 11 (2006) 7364-7373